Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

SHA:600538 Revenue

Beihai Gofar Chuanshan Biological had revenue of 97.80M CNY in the quarter ending September 30, 2026, with 14.59% growth. This brings the company's total for the last twelve months to 346.50M, up 9.63% year-over-year. In the year 2025, Beihai Gofar Chuanshan Biological had annual revenue of 328.24M, down -3.59%. That makes Beihai Gofar Chuanshan Biological the 27,740th largest company in the world by revenue and 4,784th in China.

• Revenue (ttm): 346.50M
• Revenue Growth: +9.63%
• P/S Ratio: 6.29
• Revenue / Employee: 791.10K
• Employees: 438
• Market Cap: 2.20B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Distribution [Industry] 190.47M 58.4%
• DNA Testing Equipment, Consumables and Testing Services 106.85M 32.8%
• Pharmaceutical Manufacturing 27.15M 8.3%
• Others 1.77M 0.5%

Fiscal year ended Dec 31, 2025 See the full SHA:600538 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	328.24M	-12.23M	-3.59%
Dec 31, 2024	340.47M	-28.69M	-7.77%
Dec 31, 2023	369.15M	-90.53M	-19.69%
Dec 31, 2022	459.68M	34.97M	8.23%
Dec 31, 2021	424.72M	157.02M	58.65%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error